FC
NVS icon

FIC Capital’s Novartis NVS Stock Holding History

FIC Capital’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$2.45M Sell
31,887
-279
-0.9% -$21.1K 0.93% 33
2017
Q2 		$2.41M Sell
32,166
-249
-0.8% -$17.6K 0.99% 32
2017
Q1 		$2.16M Buy
32,415
+8,877
+38% +$592K 0.96% 34
2016
Q4 		$1.54M Sell
23,538
-725
-3% -$47K 0.77% 43
2016
Q3 		$1.72M Sell
24,263
-355
-1% -$25.9K 0.77% 44
2016
Q2 		$1.82M Buy
24,618
+298
+1% +$20.6K 0.86% 41
2016
Q1 		$1.58M Buy
24,320
+5,561
+30% +$378K 0.76% 42
2015
Q4 		$1.45M Buy
18,759
+1,351
+8% +$107K 0.64% 51
2015
Q3 		$1.43M Buy
17,408
+83
+0.5% +$7.39K 0.67% 48
2015
Q2 		$1.53M Hold
17,325
– – 0.61% 53
2015
Q1 		$1.53M Sell
17,325
-167
-1% -$14.8K 0.58% 58
2014
Q4 		$1.45M Hold
17,492
– – 0.56% 59
2014
Q3 		$1.48M Sell
17,492
-112
-0.6% -$9.06K 0.59% 56
2014
Q2 		$1.43M Sell
17,604
-111
-0.6% -$8.73K 0.56% 61
2014
Q1 		$1.35M Sell
17,715
-335
-2% -$24.4K 0.55% 68
2013
Q4 		$1.3M Sell
18,050
-85
-0.5% -$5.91K 0.58% 62
2013
Q3 		$1.25M Hold
18,135
– – 0.63% 59
2013
Q2 		$1.15M Buy
+18,135
New +$1.18M 0.74% 48

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FIC Capital's NVS Position: Q3 2017 in Review

FIC Capital reduced its Novartis (NVS) stake by 0.87% in Q3 2017, selling an estimated $21.1K and leaving 31,887 shares worth $2.45M. The position accounts for 0.93% of the portfolio, ranked #33.

FIC Capital first reported a position in NVS in Q2 2013 and has held it in 18 quarters since. 937 funds tracked by Wall St. Rank hold NVS as of Q3 2017.

  • FIC Capital held 31,887 shares of Novartis worth $2.45M as of Q3 2017.
  • FIC Capital sold 279 Novartis shares in Q3 2017, an estimated $21.1K.
  • Novartis made up 0.93% of FIC Capital's portfolio in Q3 2017, its #33 holding.
  • FIC Capital first reported a position in Novartis in Q2 2013 and has held it in 18 quarters since.
  • 937 funds tracked by Wall St. Rank held Novartis as of Q3 2017.

Based on FIC Capital's 13F filing for Q3 2017, filed 14 Nov 2017.